You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
吉貝爾(688566.SH):預期未來尼羣洛爾片將呈現快速增長態勢
格隆匯 07-28 15:59

格隆匯7月28日丨有投資者向吉貝爾(688566.SH)提問:尼羣洛爾片作為公司重點推廣品種,目前有哪些具體的推廣措施?

吉貝爾回覆:尼羣洛爾片主要特點是用於治療輕中度原發性高血壓,更適用於輕中度高血壓合併心率快患者,高度切合現在高血壓治療領域關於降低血壓的同時控制心率的臨牀治療理念,其療效獲得國內頭部專家的認可和推薦。

公司採用專家推廣模式,通過全國頭部專家推薦宣傳,各省市專家及醫院醫生形成共識,進一步優化產品推廣模式,推廣效果顯著提升。另一方面,公司着力組建專門的尼羣洛爾事業部,強化新型代理平台建設,充分利用“自營+”創新模式,加強隊伍建設,隨着銷售人員的增加,覆蓋醫院數量的提升,預期未來尼羣洛爾片將呈現快速增長態勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account